The Daily - What We Know About the Omicron Variant
Episode Date: November 30, 2021The story of the Omicron variant began a week ago, when researchers in southern Africa detected a version of the coronavirus that carried 50 mutations. When scientists look at coronavirus mutations, ...they worry about three things: Is the new variant more contagious? Is it going to cause people to get sicker? And how will the vaccines work against it? We explore when we will get the answers to these three questions, and look at the discovery of the variant and the international response to it. Guest: Apoorva Mandavilli, a reporter covering science and global health for The New York Times.Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. Background reading: South African scientists have said that while they need more data to be sure, existing treatments and precautions seem to be effective against the Omicron variant.Mutations can work together to make a virus more fearsome, but they can also cancel one another out. This phenomenon, called epistasis, is why scientists are reluctant to speculate on Omicron.Almost two years into the pandemic, finger-pointing, lack of coordination, sparse information and fear are once again influencing policy.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.Â
Transcript
Discussion (0)
From New York Times, I'm Michael Barbaro.
This is The Daily.
Today.
The World Health Organization has declared that the Omicron variant of the coronavirus
poses a, quote, very high risk to public health.
quote, very high risk to public health.
I spoke with my colleague, Apoorva Mondavili,
about how it is that scientists came to that conclusion so quickly.
It's Tuesday, November 30th.
Okay, I think we're ready.
When you're ready to record, we're ready to record, so.
Really quick, we got an email about pronunciation.
I don't, is it, is it ah-mah-cron or oh-mah-cron?
I mean, I've been saying Omicron.
It's like somewhere in between.
It's neither on or off. Wait, wait, wait.
What do you say?
Omicron.
Omicron.
Omicron.
It's kind of like Omicron, but it's not Omicron.
You know what I mean?
It's like Omicron.
Can you just say it really slowly so we all can get on the same page?
Omicron.
Omicron.
Not Omicron.
Yeah, not Omicron.
I mean, I don't think it really matters that much, honestly. I'm going with Omicron. Is that okay? Omicron? Omicron, not Omicron. Yeah, not Omicron. I mean, I don't think it really matters that much, honestly.
I'm going with Omicron.
Is that okay?
Omicron, Omicron, Omicron.
Okay.
At this point, Apoorva, I'm curious, what named variant are we on now in terms of numbers?
What number is this?
We've probably seen thousands and thousands of variants of the virus.
But in terms of ones that have been important enough or of concern enough to get a Greek letter, this is seven.
And if you want to think about the ones that the World Health Organization said are really serious variants of concern, as the WHO calls them, this is number five.
So there was alpha and then beta and gamma and delta,
and now we're on Omicron.
Mm-hmm.
And we're talking to you at what feels like a curious moment
in the story of this variant, Omicron,
when public health experts have told us
that we should be worried about it,
but also not too worried
because there's so much
that they say they don't know.
So I think the best place to begin this conversation is with the question of why those experts
got so worried in the first place.
And where do you think that story starts?
The story starts in Southern Africa, where this variant was first detected.
And I want to be very clear, that's where it was first detected.
We don't know if it really originated there.
And it starts really less than a week ago.
Now, scientists in South Africa are warning of a new strain of COVID-19.
South African researchers first heard of this variant last Tuesday.
And they sequenced this variant,
which means they looked at the genetic code of
the virus, and they saw something that made them really nervous. Which is what? What did they see?
The variant, which is yet to be named, appears to have a high number of mutations.
They saw that this variant has dozens of new mutations and dozens of mutations that they had not seen before.
And that is of concern
because there's a possibility
it could be able to evade
our immune response
and be even more transmissible.
We'll explain that.
I mean, my sense from talking to you,
talking to our colleagues
on the science desk,
is that the coronavirus
mutates constantly.
So what is it about these mutations that got them anxious?
Right. The virus is always acquiring new mutations. So it's not just the number,
it's that it has a lot of mutations in parts of the virus that are really important.
So this variant has 50 mutations, and more than 30 of them are on the spike protein,
which is arguably the most important part of the virus. And of that, 26 are unique mutations,
meaning mutations that we've never seen before. By contrast, Delta had 10 unique mutations,
and Beta had six. So this is just a lot that they're seeing now in this variant.
Right.
And when scientists look at mutations within viruses, they worry about three things.
Is the variant more contagious? Is it going to cause people to get sicker?
And will vaccines continue to work against it?
This time, with this particular variant, they're seeing mutations that make them worry about all three of those things.
variant, they're seeing mutations that make them worry about all three of those things.
Hmm. So scientists are seeing mutations, just to summarize this, that could impact all three of the ways in which this variant could become a very real threat and make the pandemic worse.
Right. And they're seeing multiple mutations that they think will affect each of those
qualities that we don't want to see in a virus.
Okay.
Give us an example of a set of mutations and how it might affect one of the three categories you just mentioned, contagiousness, severity of illness, or being able to evade vaccines.
Let me pick the one that we probably worry about the most, which is, will vaccines continue
to work against this variant?
There are three main parts of this virus that are important for antibodies to recognize the virus.
In previous variants, we've seen at most mutations in two of those regions.
And that's been bad enough.
Like with the beta variant, for example, we saw mutations in two of those regions.
And the beta variant was not as sensitive to vaccines as delta or alpha.
This time, they're seeing mutations in all three of those regions.
And so that makes them worry that this one will be resistant to vaccines,
and more so even than any variant they've seen before, including beta.
and more so even than any variant they've seen before, including beta.
So you're saying that scientists immediately detect
that this variant has many, many mutations
that can make it harder for vaccinated people
to fight off this virus.
Correct.
Got it.
Okay, so let's return to this chronology for a minute.
You have these researchers in South Africa
who start to sequence the genome of this new variant.
They discover all these mutations in places on the virus
that freak them out and make them nervous.
It could make the virus more contagious,
make illness from it more severe,
and make the virus evade vaccines.
What happens next?
The scientists did what all virus researchers do these days,
which is they deposited the sequence in this database
that geneticists all over the world look at.
And scientists all over the world immediately saw the sequence,
and they all got worried.
So they agree with the scientists in South Africa
that this is a worrisome set of mutations.
They do.
In fact, one scientist told me after seeing the sequence that it was like a collection of the greatest hits of the variant that you never wanted to see together.
Huh. when all our cell phones here in the United States started buzzing around Thanksgiving with news alerts that there was a scary new variant that had been first detected in South Africa.
It was. It was the moment when scientists everywhere started to sound the alarm.
And by Friday, the day after Thanksgiving, the WHO said this was a variant of concern.
In the past, they've taken weeks to get to that point for any other variant.
And this happened just about three days after the first detection of the variant. So this has all
happened very fast. And that's because of how many mutations this new variant has.
But at this point, late last week, and correct me if I'm wrong, it seems like a lot of this
anxiety is on paper, right? It's anxiety based on what scientists are seeing in the genetic sequencing.
It's not based on sudden or alarming changes in how people are responding to this variant on the ground.
Well, not entirely.
I mean, these scientists have a reason for worrying, which is that usually when you see a cluster of mutations like this, it's because there's some advantage for the virus to have. It allows the virus to survive better.
But you're right that we don't know anything for sure yet, and that most of it is still on paper.
There are early hints from South Africa that maybe it's more severe and maybe hospitalizations
will go up, but it's just too soon to say. Let me give you an example. So,
the scientists are worried that maybe this variant won't respond to vaccines very well,
but that's not something they can just tell from looking at the sequence. So, as soon as
South African scientists found last week that this variant was circulating, immediately,
within an hour, in fact, some South African
scientists started doing those experiments. And by now, there are dozens of labs all over the world,
all trying to answer this question. Will the vaccine still work against this variant?
But we don't have an answer.
We don't have an answer yet because it takes time for these scientists to build an artificial
version of this variant that they can then test against the vaccines.
So it's probably going to be at least a couple of weeks before we know anything.
And that goes for the other two questions as well.
Got it.
So we won't be able to answer the three big questions.
Is this variant more contagious?
Does it produce greater illness?
Does it evade vaccines?
We won't know that for several weeks.
That's right.
greater illness? Does it evade vaccines?
We won't know that for several weeks.
That's right.
We have to basically wait and see is it spreading really fast?
Are a lot of people ending up in the hospital?
And then we have to wait for these lab
experiments to tell us, does it respond
to vaccines?
We'll be right back.
Of course, over the weekend at Porvo, we did not see governments around the world wait for more scientific data about the variant
or wait to react to these fears that it could be more serious.
We did not.
The White House is now restricting travel from South Africa and seven neighboring countries.
Hong Kong is also banning visitors from eight countries in Southern Africa.
Any of these countries within the last 14 days will be barred from entering Canada.
To protect the UK against the variant coming here from Southern African countries
and added four more countries to the red list.
And you can see the impulse there.
You know, they're all scrambling to contain the spread of the virus.
And many countries declared right away
that they were going to restrict visitors from Southern African countries.
We are raising a red flag.
We understand that we're on the verge of a state of emergency.
And some, like Israel, Japan, and Morocco,
decided that they would bar all foreign visitors.
But, you know, I'm not sure that really works
because as of today, the virus is already in at least 15 countries.
Well, I think that brings us up to now, where we have countries imposing these travel restrictions and simultaneously finding that the virus is already inside their borders.
So I think a question that many people have is, do these travel restrictions, which seem to be the world's primary response while we wait these two weeks for results on all this research, do they make any sense?
Pretty much every public health expert I talk to says they don't, that these travel bans do really nothing.
They may delay it a tiny bit, but really by the time countries discover that there is a variant that's circulating, that variant is already everywhere.
Good morning. The prime minister is urging calm after the new coronavirus variant called Omicron was detected in Australia.
It's been in several European countries. It's in Canada. It's in Hong Kong. It's in Australia.
Also today, Britain, Germany and Italy announced their first Omicron cases.
They follow Belgium.
You almost have to expect that it's going to eventually find its way into Canada.
I think people were expecting.
Really, the world does not sequence enough of the virus, detect enough of the virus to be able to know which variants are circulating.
So by the time anybody has sounded an alarm, the horse has left the barn already.
So by the time the U.S., for example, as we just have, says no travelers from eight countries
across Southern Africa, it's too late. You know, today, President Biden said it's probably just a
matter of time before it's here. Travel restrictions can slow the speed of Omicron.
It cannot prevent it. But here's what
it does. It gives us time. But really, I think the scientists that I've talked to say it's probably
here already. We just don't know that it is. And the other problem with these travel restrictions
is that to the people in those countries, it feels like a punishment. It basically disincentivizes
them from telling the
world that there is this dangerous new variant that's circulating. Why would it disincentivize
them from sharing a variant with the world? Now, these restrictions are completely unjustified
and unfairly discriminate against our country and our Southern African sister countries.
When you block visitors from those countries and you impose these travel bans,
you're delivering a huge economic blow to a lot of those countries.
And they were already doing poorly because of the pandemic till now.
The prohibition of travel is not informed by science,
nor will it be effective in preventing the spread of this variant?
So the South African officials and the scientists that I've been talking to are very upset because
they feel that they did the world a favor by alerting everybody to this variant. There are
scientists from all over the world asking them for samples and for sequences. And at the same time,
they're being told you're not welcome in our country.
The only thing the prohibition on travel will do is to further damage the economies of the
affected countries and undermine their ability to respond to and also to recover from the pandemic.
So it makes sense that the South African president just came out and said,
you know, please lift these travel restrictions because it's really unfair. On the subject of Southern Africa, Apoorva, what, if anything, should we
make of the fact that this is where this variant was first detected? Well, we know one thing about africa which is that very few people in that continent have been
vaccinated and scientists have been saying for months now that the more people we leave unvaccinated
in certain parts of the world the higher the chances that we'll see a dangerous new variant
in africa in particular there are a lot of people who have weak immune systems,
whether that's because of HIV or TB or malaria or these diseases that really sap people's strength.
There are a lot of immunocompromised people. And we know now that the virus acquires mutations
the best in somebody who is immunocompromised. Can you just explain that?
in somebody who is immunocompromised.
Can you just explain that?
In somebody who is immunocompromised,
the virus will continue to replicate,
to multiply for a long time at a very low level.
So it's like giving the virus this playing ground to experiment and come up with all kinds of new mutations.
When you see a variant like Omicron that has 50 new mutations,
it's usually because it's had a lot of time in one person rather than that it acquired them one at a time, you know,
in different people. Got it. This is basically what scientists have been warning us for months,
that apart from, you know, the moral argument for vaccinating the world, we're really rolling the
dice when we leave hundreds of millions of people unprotected
in parts of the world where the virus can really gain a foothold and really replicate and acquire
a lot of new mutations. But isn't it possible that an immunocompromised person anywhere in the world
could have given us this variant? Absolutely. That's a really excellent point. This is why we should be vaccinating as
much of the world as we can. The more people we have unvaccinated, the more chances that we'll
see another variant that's dangerous. But what if this variant, as many scientists fear,
is resistant to vaccines? Does that still hold true? It's not all or nothing.
It's not that if this variant is not as sensitive to vaccines
that the vaccines don't work at all.
It just means that they'll be a little less effective,
but they'll still probably prevent most people
from getting really sick.
And the vaccines are really still our best defense
against this virus.
And that's even more true for boosters because they really amp up your antibody levels and they'll give you an even
better chance of fighting off this variant. So it sounds like you and the experts you talk to
are saying that the answer to preventing variants like Omicron and enduring them is not severe travel restrictions. It's just a lot more
vaccinations. We know what works. It's vaccination, it's masks, it's social distancing, and probably
not travel restrictions.
Approval, we started this conversation with an acknowledgement that public health officials are telling us to be worried, but not too worried.
And I wonder if that's where your head is right now.
It really is because we don't know enough to panic yet.
I think this is one of those very frustrating moments when we just have to wait for the answers.
And until we know that we should panic, not panic.
for the answers, and until we know that we should panic, not panic.
Well, Purva, when we get that answer, we will turn to you again.
For now, thank you very much.
Thank you.
On Monday night, in response to the emergence of Omicron,
U.S. officials changed their recommendation for booster shots. Instead of saying that most American adults may get booster shots depending
on their individual needs, regulators said that adults should get booster shots to strengthen
their immunity.
We'll be right back.
Here's what else you need to know today.
On Monday, the U.S. Secretary of Defense ordered a new high-level investigation into a 2019 airstrike
in Syria that killed dozens of women and children. The airstrike was deliberately
hidden by the U.S. military until it was uncovered by the New York Times.
And in testimony on Monday, Elizabeth Holmes, the former Theranos CEO accused of defrauding investors,
testified that her ex-business and romantic partner, Sonny Balwani, attempted to manipulate her.
The testimony suggested a legal strategy of potentially blaming Balwani for affecting Holmes' decision-making
when she ran Theranos and oversaw its collapse.
Today's episode was produced by Jessica Chung,
Diana Nguyen, and Michael Simon-Johnson.
It was edited by M.J. Davis-Lynn
and engineered by Chris Wood.
Our theme music is by Jim Brunberg
and Ben Landsberg of Wonderly.
That's it for The Daily.
I'm Michael Barbaro.
See you tomorrow.